Small Molecule for White Matter Injury

About Medosome Biotec

Medosome Biotec is a private, preclinical-stage biotech focused on addressing unmet needs in pediatric healthcare through precision medicine. Its core strategy involves developing companion diagnostics, such as genetic tests for rare disease diagnosis and pharmacogenomic-guided dosing, alongside therapeutic programs for conditions like white matter injury in infants. The company appears to be pre-revenue, leveraging scientific and entrepreneurial expertise to advance early-stage technologies from late discovery through IND/Phase I readiness.

Therapeutic Areas